Tate & Lyle stock faces a USD 3.6 billion acquisition

Tate & Lyle stock stood at GBp 558.00 on the London Stock Exchange on September 21, 2026, placing it 3.8 percent below the 52-week high of GBp 580.00. The company is also at the center of Ingredion's planned USD 3.6 billion acquisition, giving investors a transaction-driven reference point for the shares.

USD 3.6 billion deal shapes the story

As Yahoo Finance reported on September 17, 2026, Ingredion's purchase is designed to expand its texture and health-focused ingredients business as food producers reformulate products around health and taste.

Yahoo Finance reported on September 22, 2026, that Tate & Lyle shareholders accepted Ingredion's cash offer in July, while completion is expected in the second half of 2027 subject to regulatory conditions. That timetable makes the transaction outcome more important than a single trading session.

Revenue gives the deal scale

Tate & Lyle reported GBP 2.0 billion in revenue from continuing operations for the year ended March 31, 2026, according to the Tate & Lyle release dated September 10, 2026. The revenue figure provides a direct scale comparison with the USD 3.6 billion transaction value, although the two figures use different currencies and represent different measures.

For investors, the key distinction is between operating performance and deal execution. The fiscal 2026 revenue figure describes the business being acquired, while the planned closing in the second half of 2027 defines the timetable for converting the offer into a completed transaction.

Stock stays below yearly high

Tate & Lyle stock was quoted at GBp 558.00 on September 21, 2026. The 52-week range was GBp 319.40 to GBp 580.00, leaving the price GBp 22.00 below the upper end and 3.8 percent below that high.